fairness and accountability in medical ML; and (b) makes FL models especially vulnerable to data poisoning attacks. It then identifies several key claims about the expected benefits of FL in healthcare and argues that they may be either exaggerated, misleading, or incomplete - often due to the problem of federation opacity.
No takes yet. Share an insight, caveat, or question.
Hatherley et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: